Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
FDA Approval Summary: Niraparib plus Abiraterone Acetate Fixed-Dose Combination for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 12, 2025
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer.
Journal: Breast cancer research and treatment
Published: April 28, 2021
An FDA Review of Drug Development in Nonmetastatic Castration-resistant Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 03, 2019
Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis.
Journal: The Lancet. Oncology
Published: September 14, 2017
FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 24, 2017
The influence of delipidation on triglyceride and LIPIN1 of porcine embryos derived from parthenogenetic activation.
Journal: Reproduction in domestic animals = Zuchthygiene
Published: January 23, 2017
Influence of Delipation on the Energy Metabolism in Pig Parthenogenetically Activated Embryos.
Journal: Reproduction in domestic animals = Zuchthygiene
Published: May 25, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026